Company: ABBV
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001551152-25-000040
Chunk: 8

Company: AbbVie Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 2
Chunk 8
---
7.8 %11.3 %Total$691 $637 8.5 %8.3 %$1,356 $1,251 8.4 %10.3 %ElahereUnited States$138 $128 8.0 %8.0 %$303 $192 57.5 %57.5 %International21 — n/mn/m35 — n/mn/mTotal$159 $128 24.2 %23.7 %$338 $192 75.5 %75.5 %EpkinlyCollaboration revenues$49 $29 70.5 %70.5 %$85 $51 66.8 %66.8 %International21 7 >100.0 %>100.0 %36 12 >100.0 %>100.0 %Total$70 $36 93.9 %92.3 %$121 $63 92.1 %93.3 %Other OncologyUnited States$2 $— n/mn/m$2 $— n/mn/mAestheticsBotox CosmeticUnited States$410 $450 (8.7)%(8.7)%$705 $839 (15.9)%(15.9)%International282 279 0.9 %1.2 %543 523 3.7 %5.8 %Total$692 $729 (5.0)%(4.9)%$1,248 $1,362 (8.4)%(7.6)%

2025 Form 10-Q | 31

Three months endedJune 30,Percent changeSix months endedJune 30,Percent changeAt actual currency ratesAt constant currency ratesAt actual currency ratesAt constant currency rates(dollars in millions)2025202420252024Juvederm CollectionUnited States$105 $138 (23.6)%(23.6)%$180 $244 (25.9)%(25.9)%International155 205 (24.4)%(24.4)%311 396 (21.5)%(19.8)%Total$260 $343 (24.0)%(24.